Listening to fistulas: sound may reveal hidden clots in dialysis patients
NCT ID NCT06411353
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study looks at whether the sounds made by blood flowing through an arteriovenous fistula (AVF) can tell doctors how healthy the fistula is. Researchers will use MRI and ultrasound to measure blood flow and compare it to the sounds recorded. If a clear link is found, it could lead to a simple, non-invasive way to monitor AVFs in people with end-stage kidney disease who need dialysis.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could lead to a non-invasive way to monitor fistula health using sound, potentially reducing complications in dialysis patients.
- What could go wrong
- This is a small, early-stage study with only 15 participants, so results may not apply broadly. The link between sound and blood flow may not be strong enough for clinical use.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for END-STAGE RENAL DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
A.O. Papa Giovanni XXIII - U.O. Nefrologia e Dialisi
RECRUITINGBergamo, Bergamo, 20147, Italy
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new drug work safely in patients with kidney failure?
- What does life feel like for children with a rare birth defect? a new study asks
- AI therapy coach aims to ease distress in seriously ill seniors
- A simple stretch during dialysis might soothe restless legs
- A regenerative graft could rethink dialysis access
- Pumpkin seed oil may fight inflammation in kidney patients — a trial puts it to the test